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INTRODUCTION
Cerebrospinal fluid (CSF) fistula is a common neurosur-
gical complication, occurring in 1% to 27% of cases. The 
main clinical manifestations are postural headache, nau-
sea, dizziness, photophobia, and tinnitus. This condition 
may be associated with inadequate wound healing and 
infection, meningitis, and pseudomeningocele, factors 
that increase patient morbidity and mortality. 
Despite the limitations, hermetic closure of the dura 
mater has been recommended for the prevention and 
treatment of CSF fistula. In recent years, techniques have 
been developed to reinforce the site of the dura mater 
closure, such as additional suture, autologous tissue 
grafts, fibrin sealants, and collagen sponges. DuraSeal is 
a dura mater sealant consisting of polyethylene glycol hy-
drogel (PEG hydrogel), to be applied at the site of suture, 
and has been indicated for head and spinal surgery with 
opening of the dura mater.
METHODS
A systematic review was performed in MEDLINE, 
EMBASE, and Scielo/Lilacs databases, recovering a to-
tal of 365 articles using the following search strategies: 
((duraseal OR dura seal OR polyethylene glycol hy-
drogel OR dura seal dural sealant system OR dura-seal 
OR polyethylene glycols OR dura seal xact adhesion bar-
rier and sealant system OR hydrogel) AND (neurosur-
gical procedures OR neurosurgery OR cranial surgery)) 
AND random*. The analysis of 365 articles was based on 
their titles and abstracts. Six articles met the inclusion 
criteria (randomized clinical trial study design, compar-
ing the use of DuraSeal to suture with or without comple-
mentary methods of dura mater closure, and having as 
outcome the development of CSF fistula and other com-
plications). These articles were critically appraised using 
the Jadad score1. 
RESULTS
Two studies were selected. Of these, one refers to the use 
of DuraSeal in head surgeries (Jadad: 1)2, and another to 
the use of DuraSeal in spinal surgeries (Jadad: 3)3. 
The study by Kim et al.2 evaluated the use of DuraSeal 
in spinal surgeries. The sample included 158 patients who 
were randomized (102 patients in the intervention group 
and 56 in the control group). The primary outcome was 
CSF fistula; the secondary outcome, other complications. 
Patient follow-up was performed during the immedi-
ate postoperative period, after 30 and 90 days. This study 
demonstrated that the use of DuraSeal in spinal surgeries 
is associated with absolute risk reduction (ARR) in 35.6% 
(95% CI: 23.0%-48.2%) and NNT of 3 for CSF fistula; there 
was no difference between the control and intervention 
groups regarding the development of further complications. 
The study by Osbun et al.3 analyzed the use of Du-
raSeal in head surgeries and consisted of 237 randomized 
patients (120 in the intervention group and 117 in the 
control group), having CSF fistula as the primary out-
come and other complications as the secondary outcome. 
Patients were followed for 30 days. There was no decrease 
in the incidence of neurosurgical complications, includ-
ing CSF leak, as well as incisional complications.
SYNTHESIS OF AVAILABLE EVIDENCE 
t 1BUJFOUT VOEFSHPJOH TQJOBM TVSHFSZ VTJOH %VSB4FBM
when compared to suturing with or without fibrin 
sealant, showed a decrease in the absolute risk of CSF 
fistula (ARR: 35.6% and NNT: 3), with no increased 
risk of complications.
t 1BUJFOUT VOEFSHPJOH IFBE TVSHFSZ VTJOH %VSB4FBM
when compared to suturing with or without fibrin 
sealant, showed no reduction in the absolute risk of 
neurosurgical complications, including CSF leak, and 
no decrease in the risk of incisional complications. 
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